The iMTATs™ software was developed over the past decade by Milramco LLC, in collaboration with a number of partners, including KnarrTek Inc., under the direction of Dr. Peter Green.
iMTATs is the result several million dollars of investment and over a decade of development in which the iMTATs software has been successfully applied to a wide range of FDA regulated applications in areas such as food and pharmaceutical processing as well as the making of cosmetics, medical devices and supplies, and over the counter pharmaceuticals.
iMTATs has its roots in Real-Time Decision Support research performed by Dr. Green at MIT and WPI, funded by DARPA, the USAF, and NASA as well as in the underlying BellHawk® and MilramX™ software.
iMTATs is sold and supported in the USA by KnarrTek Inc., which also collaborates with Milramco in its ongoing development.
Milramco also licenses iMTATs directly to larger organizations that have their own IT department that are capable of integrating iMTATs directly into their own enterprise IT architecture.
iMTATs is also available for licensing to solution integrator partners in the USA or to other organizations outside the USA directly through Milramco.
For more details about the underlying technology, please see www.BellHawk.com and www.MilramX.com.
Please see Milramco Partner Opportunities page for more details if you wish to become a Milramco partner.